Aclarion, Inc. – NASDAQ:ACON
Aclarion stock price today
Aclarion stock price monthly change
Aclarion stock price quarterly change
Aclarion stock price yearly change
Aclarion key metrics
Market Cap | 1.26M |
Enterprise value | N/A |
P/E | -0.55 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 102.13 |
Price/Book | 3.45 |
PEG ratio | 0.01 |
EPS | -6.67 |
Revenue | 60.04K |
EBITDA | -4.48M |
Income | -6.12M |
Revenue Q/Q | -60.29% |
Revenue Y/Y | -21.90% |
Profit margin | -12582.79% |
Oper. margin | -10090.85% |
Gross margin | -8.03% |
EBIT margin | -10090.85% |
EBITDA margin | -7464.59% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAclarion stock price history
Aclarion stock forecast
Aclarion financial statements
| Jun 2023 | 17.07K | -1.46M | -8578.71% |
|---|---|---|---|
| Sep 2023 | 19.06K | -998.01K | -5234.78% |
| Dec 2023 | 13.79K | -1.26M | -9171.17% |
| Mar 2024 | 10.11K | -2.39M | -23720.61% |
| 2025 | 200K | -144.77K | -72.39% |
|---|
Analysts Price target
Financials & Ratios estimates
| 2024-05-15 | -0.57 | -0.44 |
|---|
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | |
| 2022 | 11.73% |
| 2023 |
| Jun 2023 | 2004466 | 1.99M | 99.49% |
|---|---|---|---|
| Sep 2023 | 1543219 | 2.37M | 153.65% |
| Dec 2023 | 2459774 | 3.18M | 129.6% |
| Mar 2024 | 3727262 | 1.22M | 32.78% |
| Jun 2023 | -947.54K | -60.91K | 1.16M |
|---|---|---|---|
| Sep 2023 | -952.51K | -12.96K | 522.41K |
| Dec 2023 | -744.49K | -33.91K | 1.62M |
| Mar 2024 | -2.38M | -63.65K | 3.55M |
Aclarion alternative data
| Aug 2023 | 7 |
|---|---|
| Sep 2023 | 7 |
| Oct 2023 | 7 |
| Nov 2023 | 7 |
| Dec 2023 | 7 |
| Jan 2024 | 7 |
| Feb 2024 | 7 |
| Mar 2024 | 4 |
| Apr 2024 | 4 |
| May 2024 | 4 |
| Jun 2024 | 4 |
| Jul 2024 | 4 |
Aclarion other data
-
What's the price of Aclarion stock today?
One share of Aclarion stock can currently be purchased for approximately $7.1.
-
When is Aclarion's next earnings date?
Unfortunately, Aclarion's (ACON) next earnings date is currently unknown.
-
Does Aclarion pay dividends?
No, Aclarion does not pay dividends.
-
How much money does Aclarion make?
Aclarion has a market capitalization of 1.26M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.75% to 75.4K US dollars. Aclarion made a loss 4.91M US dollars in net income (profit) last year or -$0.44 on an earnings per share basis.
-
What is Aclarion's stock symbol?
Aclarion, Inc. is traded on the NASDAQ under the ticker symbol "ACON".
-
What is Aclarion's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Aclarion?
Shares of Aclarion can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Aclarion have?
As Jul 2024, Aclarion employs 4 workers.
-
When Aclarion went public?
Aclarion, Inc. is publicly traded company for more then 3 years since IPO on 22 Apr 2022.
-
What is Aclarion's official website?
The official website for Aclarion is aclarion.com.
-
Where are Aclarion's headquarters?
Aclarion is headquartered at 951 Mariners Island Boulevard, San Mateo, CA.
-
How can i contact Aclarion?
Aclarion's mailing address is 951 Mariners Island Boulevard, San Mateo, CA and company can be reached via phone at +65 02411741.
Aclarion company profile:
Aclarion, Inc.
aclarion.comNASDAQ
4
Medical - Healthcare Information Services
Healthcare
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
San Mateo, CA 94404
CIK: 0001635077
ISIN: US6551872012
CUSIP: 655187102
